UPDATE 1-Amgen's Sjogren's drug cuts disease activity in trial

(Adds details and background throughout) Nov 11 (Reuters) – Amgen said on Wednesday a detailed late-stage trial data showed its experimental drug for the Sjogren's disease significantly reduced

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)